MorningSight Capital is a well-established boutique investment banking firm
specializing in the financing of science-driven growth companies globally.
MorningSight's partners possess a deep background in medical devices,
industrial technology, the natural and medical sciences and patent law.
Representative Transactions:
Niton - Thermo Analyzers
Betagene
Sopharmia (Gladius) Pharmaceuticals
Enigma Information Systems
The firm has extensive experience in private placements of
debt and equity transactions and alternative asset funds.
MorningSight offers business restructuring and advisory services.
Raised $100+ million for new ventures and turn-arounds.
* * *
Lawrence Obstfeld
Managing Director
MorningSight Capital, LLC
+1-646-741-2103 xt 700
specializing in the financing of science-driven growth companies globally.
MorningSight's partners possess a deep background in medical devices,
industrial technology, the natural and medical sciences and patent law.
Representative Transactions:
Niton - Thermo Analyzers
Betagene
Sopharmia (Gladius) Pharmaceuticals
Enigma Information Systems
The firm has extensive experience in private placements of
debt and equity transactions and alternative asset funds.
MorningSight offers business restructuring and advisory services.
Raised $100+ million for new ventures and turn-arounds.
* * *
Lawrence Obstfeld
Managing Director
MorningSight Capital, LLC
+1-646-741-2103 xt 700